MyFinsight
Home
Blog
About
Marketable securities
$531,000K
(140.09%↑ Y/Y)
Cash and cash
equivalents
$90,104K
(29.78%↑ Y/Y)
Prepaid expenses and
other current assets
$5,382K
(-17.21%↓ Y/Y)
Other receivables
$4,920K
(107.59%↑ Y/Y)
Total property and
equipment, at cost
$61,484K
(17.15%↑ Y/Y)
Total current assets
$631,406K
(110.84%↑ Y/Y)
Property and equipment,
net
$29,932K
(3.03%↑ Y/Y)
Operating lease
right-of-use assets
$24,056K
(-6.30%↓ Y/Y)
Restricted cash
$4,939K
(-0.22%↓ Y/Y)
Other long-term
assets
$828K
(86.07%↑ Y/Y)
Less accumulated
depreciation
$31,552K
(34.67%↑ Y/Y)
Total assets
$691,161K
(92.21%↑ Y/Y)
Total liabilities and
stockholders' equity
$691,161K
(92.21%↑ Y/Y)
Total stockholders'
equity
$487,281K
(81.77%↑ Y/Y)
Total liabilities
$203,880K
(122.81%↑ Y/Y)
Accumulated deficit
-$565,114K
(-39.88%↓ Y/Y)
Accumulated other
comprehensive loss
-$5,165K
(-53.13%↓ Y/Y)
Additional paid-in capital
$1,057,551K
(56.57%↑ Y/Y)
Deferred revenue, net of
current
$105,623K
(1210.62%↑ Y/Y)
Total current
liabilities
$59,658K
(42.55%↑ Y/Y)
Operating lease
liability, net of current
$33,357K
(-9.94%↓ Y/Y)
Defined benefit plan
liability
$5,242K
(15.01%↑ Y/Y)
Common stock, 0.0001
par value...
$9K
(50.00%↑ Y/Y)
Accrued expenses and
other current...
$25,773K
(87.21%↑ Y/Y)
Current deferred
revenue
$22,103K
(20.06%↑ Y/Y)
Accounts payable
$7,152K
(28.15%↑ Y/Y)
Current portion of
operating lease liability
$4,630K
(13.09%↑ Y/Y)
Back
Back
Balance Sheet
Monte Rosa Therapeutics, Inc. (GLUE)
Monte Rosa Therapeutics, Inc. (GLUE)
source: myfinsight.com